Literature DB >> 30653245

Skin Cancer Associated Genodermatoses: A Literature Review.

Juliane Schierbeck1, Tine Vestergaard, Anette Bygum.   

Abstract

Skin cancer has become the most common type of cancer worldwide as a result of environmental exposure and medical treatments. A small group of patients are genetically predisposed to skin cancer and this article is intended as a diagnostic tool when encountering patients with multiple skin cancer lesions. The disorders are described with clinical characteristics, genetics and management. The most common syndromes associated with basal cell carcinoma are: Gorlin-Goltz syndrome, Rombo syndrome, and Bazex-Dupré-Christol syndrome. Multiple squamous cell carcinomas can be related to: xeroderma pigmentosum, Ferguson-Smith, Muir-Torre syndrome, Mibelli-type porokeratosis, keratitis-ichthyosis-deafness syndrome, Rothmund-Thomson syndrome, Bloom syndrome, and epidermodysplasia verruciformis. Malignant melanoma can be inherited, as in familial atypical multiple mole melanoma syndrome.

Entities:  

Keywords:  basal cell carcinoma; genodermatoses; hereditary skin cancer; skin cancer; squamous cell carcinoma

Mesh:

Substances:

Year:  2019        PMID: 30653245     DOI: 10.2340/00015555-3123

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  14 in total

1.  Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy.

Authors:  Lihi Atzmony; Young H Lim; Claire Hamilton; Jonathan S Leventhal; Annette Wagner; Amy S Paller; Keith A Choate
Journal:  J Am Acad Dermatol       Date:  2019-08-23       Impact factor: 11.527

2.  Introduction to phacomatoses (neurocutaneous disorders) in childhood.

Authors:  Martino Ruggieri; Agata Polizzi; Gioacchino Paolo Marceca; Stefano Catanzaro; Andrea D Praticò; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2020-09-17       Impact factor: 1.475

Review 3.  Multidisciplinary approach to Gorlin-Goltz syndrome: from diagnosis to surgical treatment of jawbones.

Authors:  Francesco Spadari; Federica Pulicari; Matteo Pellegrini; Andrea Scribante; Umberto Garagiola
Journal:  Maxillofac Plast Reconstr Surg       Date:  2022-07-18

4.  Multiple Basal Cell Carcinomas in Immunocompetent Patients.

Authors:  Paola Savoia; Federica Veronese; Lara Camillo; Vanessa Tarantino; Ottavio Cremona; Elisa Zavattaro
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

5.  Human Papillomavirus-induced Cutaneous and Mucosal Lesions in a Patient with Rothmund-Thomson Syndrome.

Authors:  Thomas Kuntz; Bijan Koushk-Jalali; Christian Tigges; Steffi Silling; Frank Oellig; Cristina Has; Monika Hampl; Ulrike Wieland; Alexander Kreuter
Journal:  Acta Derm Venereol       Date:  2020-08-19       Impact factor: 3.875

Review 6.  Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?

Authors:  Anja Wessely; Theresa Steeb; Ulrike Leiter; Claus Garbe; Carola Berking; Markus Vincent Heppt
Journal:  Int J Mol Sci       Date:  2020-12-06       Impact factor: 5.923

7.  Downregulation of lncRNA NEAT1 inhibits the proliferation of human cutaneous squamous cell carcinoma in vivo and in vitro.

Authors:  Zhenhua Gong; Guoliang Shen; Chunhui Huang; Jianchao Zhang; Jianfeng Ji
Journal:  Ann Transl Med       Date:  2022-01

Review 8.  Cutaneous Expression of Familial Cancer Syndromes.

Authors:  Anne-Johanne Andersen; Juliane Schierbeck; Anette Bygum; Nieves Puente-Pablo
Journal:  Acta Derm Venereol       Date:  2021-07-30       Impact factor: 3.875

Review 9.  Basal Cell Carcinoma: A Comprehensive Review.

Authors:  Emi Dika; Federica Scarfì; Manuela Ferracin; Elisabetta Broseghini; Emanuela Marcelli; Barbara Bortolani; Elena Campione; Mattia Riefolo; Costantino Ricci; Martina Lambertini
Journal:  Int J Mol Sci       Date:  2020-08-04       Impact factor: 5.923

10.  Association between single nucleotide polymorphisms of IL-6 and susceptibility to skin cancer: a meta-analysis and systematic review.

Authors:  Keye Guo; Zhongming Lu; Xiaoping Wang; Jianjun Qiao
Journal:  Transl Cancer Res       Date:  2021-12       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.